3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Barbara Zahorska‐Markiewicz et al.|The Lancet|2017Cited by 843
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1Bryan R. Haugen, E. Chester Ridgway, Furio Pacini et al.|The Journal of Clinical Endocrinology & Metabolism|1999Cited by 564
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of CytologySilvia Cantara, Furio Pacini, Marco Capezzone et al.|The Journal of Clinical Endocrinology & Metabolism|2010Cited by 316
A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone WithdrawalPamela Schroeder, Paul W. Ladenson, Bryan R. Haugen et al.|The Journal of Clinical Endocrinology & Metabolism|2006Cited by 198
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient PatientsMaria Grazia Castagna, Domenico Salvatore, Monica Dentice et al.|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 155